These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

67 related articles for article (PubMed ID: 5602127)

  • 1. [A synchronized diastolic microinjecctor. Possibilities of its utilization in acute coronary insufficiency].
    Courbier R; Baille Y; Goudard A; Bourgade P; Henry E
    Agressologie; 1967; 8(2):195-9. PubMed ID: 5602127
    [No Abstract]   [Full Text] [Related]  

  • 2. [Isoptin studies on normal subjects and patients with coronary disease].
    Knoch G; Schlepper M; Witzleb E
    Med Klin; 1963 Sep; 58(36):1485-9. PubMed ID: 5889185
    [No Abstract]   [Full Text] [Related]  

  • 3. [Experience with the use of high intravenous doses of a coronary-active drug in the treatment of acute and chronic coronary insufficiency].
    Cinelli P; Grazzini M
    Minerva Cardioangiol; 1969 May; 17(5):317-23. PubMed ID: 5814987
    [No Abstract]   [Full Text] [Related]  

  • 4. Preconditioning the human myocardium with intracoronary adenosine.
    Lochan R
    Indian Heart J; 1999; 51(3):346. PubMed ID: 10624082
    [No Abstract]   [Full Text] [Related]  

  • 5. [Diameter changes of epicardial coronary arteries and coronary stenoses after intracoronary application of SIN 1, a molsidomine metabolite].
    Schulz W; Wendt T; Scherer D; Kober G
    Z Kardiol; 1983 Jul; 72(7):404-9. PubMed ID: 6613236
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Local arterial drug delivery: a golden gun without bullets?
    Schwartz RS; Lubbe D; Altman J; Holmes DR
    J Invasive Cardiol; 1999 Oct; 11(10):620-1. PubMed ID: 10745445
    [No Abstract]   [Full Text] [Related]  

  • 7. The changes of fractional flow reserve after intracoronary nitrate and Nicorandil injection in coronary artery ectasia.
    Kim W; Jeong MH; Ahn YK; Cho JG; Park JC; Kang JC
    Int J Cardiol; 2006 Nov; 113(2):250-1. PubMed ID: 16290224
    [No Abstract]   [Full Text] [Related]  

  • 8. [Acute nitrate--essential in coronary heart disease].
    MMW Fortschr Med; 2009 Jun; 151(25):48-9. PubMed ID: 19739525
    [No Abstract]   [Full Text] [Related]  

  • 9. [Treatment of coronary insufficiency by carbocromen (apropos of 40 cases)].
    Queneau P; Le Guyader J; Pont M
    Rev Lyon Med; 1967 Nov; 16(18):753-7. PubMed ID: 5621963
    [No Abstract]   [Full Text] [Related]  

  • 10. [Effects of intravenous administration of nitroglycerin and SIN-1 or molsidomine on epicardial arterial diameter in patients with stable coronary heart disease].
    Münzel T; Kurz S; Heitzer T; Luhmann C; Just H
    Med Klin (Munich); 1994 Jul; 89 Suppl 2():38-41. PubMed ID: 7968900
    [No Abstract]   [Full Text] [Related]  

  • 11. [Proceedings: Effects of simultaneous administration of coronary vasodilator agents and anti-sclerosis agents].
    Kuno K; Takahashi T; Yoshimura M; Hasegawa G; Otsuka F
    Jpn Circ J; 1975 Jun; 39(6):730. PubMed ID: 1152236
    [No Abstract]   [Full Text] [Related]  

  • 12. Pleiotropic effects of cardilopin (secondary coronary prevention).
    Kapanadze S; Dolidze N; Bakhutashvili Z; Chapidze L; Shengelia E
    Georgian Med News; 2005 Feb; (119):46-8. PubMed ID: 15834180
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Clinico-experimental observations during the single intervenous and the long-duration oral administration of a coronary vasodilator].
    Storck U
    Med Welt; 1965 Dec; 52():2926-31. PubMed ID: 5888445
    [No Abstract]   [Full Text] [Related]  

  • 14. [Treatment of arteritis of the lower extremities by daily intra-arterial perfusion].
    Journ Annu Diabetol Hotel Dieu; 1969; 10():417-8. PubMed ID: 5385070
    [No Abstract]   [Full Text] [Related]  

  • 15. Letter of comment on "Intracoronary nitroprusside for the prevention of the no-reflow phenomenon after primary percutaneous coronary intervention in acute myocardial infarction. A randomized, double-blind, placebo-controlled clinical trial" (Am Heart J 2006;152:887.e9-14).
    Vydt T; Agostoni P
    Am Heart J; 2007 May; 153(5):e25; author reply e27. PubMed ID: 17452140
    [No Abstract]   [Full Text] [Related]  

  • 16. [Treatment of arterial hypertension in the presence of coronary insufficiency].
    da Cunha GP
    Arq Bras Cardiol; 1980 Apr; 34(4):315-9. PubMed ID: 7436792
    [No Abstract]   [Full Text] [Related]  

  • 17. [Diastolic heart function. Pathophysiology, possibilities for evaluation and modifiability].
    Modersohn D; Walde T; Bruch L
    Z Arztl Fortbild (Jena); 1993 Feb; 87(2):111-21. PubMed ID: 8094928
    [No Abstract]   [Full Text] [Related]  

  • 18. [Clinical evaluation of intensain--coronary vasodilator agent].
    Hruczkowska E; Korolko A
    Pol Tyg Lek; 1969 Jun; 24(26):1012-3. PubMed ID: 5805068
    [No Abstract]   [Full Text] [Related]  

  • 19. [Use of peripheral vasodilator agents in chronic cardiac insufficiency].
    Zhukova AA; Eliseev OM
    Vopr Revm; 1982; (1):48-55. PubMed ID: 7046243
    [No Abstract]   [Full Text] [Related]  

  • 20. [Treatment of heart and coronary insufficiency with Intensain Lanicor].
    Kligge H
    Munch Med Wochenschr; 1966 May; 108(21):1169-76. PubMed ID: 6014174
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.